Zobrazeno 1 - 10 of 236 pro vyhledávání: '"Golbe LI"'
1
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)
Autor: Dam, T, Golbe, LI, Hoglinger, GU, Grundman, M, Yang, LL, Tidemann-Miller, B, Kupferman, J, Harper, K, Kamisoglu, K, Wald, MJ, Graham, DL, Gedney, L, O'Gorman, J, Haeberlein, SB, Aiba, I, Antonini, A, Apetauerova, D, Azulay, JP, Martinez, EB, Bang, J, Barone, P, Barrett, M, Bega, D, Berg, D, Corrales, KB, Bordelon, Y, Boxer, AL, Brandt, M, Brueggemann, N, Castelnovo, G, Ceravolo, R, Chuang, RD, Chung, SJ, Church, A, Corvol, JC, Cudia, P, Dale, M, Defebvre, L, Drapier, S, Driver-Dunckley, ED, Ebersbach, G, Eggert, KM, Ellenbogen, A, Eusebio, A, Evans, AH, Fedorova, N, Finger, E, Foubert-Samier, A, Ghosh, B, Golbe, L, Perez, FG, Grossman, M, Hall, D, Hamada, K, Hasegawa, K, Hoeglinger, G, Honig, L, Houghton, D, Huang, XM, Isaacson, S, Koh, S, Bojarski, JK, Lang, ANE, Leigh, PN, Litvan, I, Lozano, JJL, Moreno, JLLS, Ludolph, AC, Piudo, MRL, Torres, IM, McFarland, N, Meissner, W, Mestre, T, Rivera, PM, Molho, E, Mollenhauer, B, Morris, HR, Murata, M, Obi, T, Magne, FO, O'Suilleabhain, P, Pahwa, R, Pantelyat, A, Pavese, N, Pokhabov, D, Prudlo, J, Rodriguez-Porcel, F, Rowe, J, Savitt, J, Schnitzler, A, Schulz, JB, Seppi, K, Shah, BI, Shill, H, Shprecher, D, Stamelou, M, Steiger, M, Takahashi, Y, Takigawa, H, Tartaglia, C, Toenges, L, Truong, D, Tse, W, Tuite, P, Volc, D, Wills, AMA, Woitalla, D, Xie, T, Yuasa, T, Zauber, SE, Zesiewicz, T
Publikováno v: NATURE MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c4d2fa80ba30f6be89ae19d1c2727383
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=13862
Zobrazit plný text záznamu
3
Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale
Autor: Hewer, S, Varley, S, Boxer, AL, Paul, E, Williams, DR, Azulay, JP, Benecke, R, Boeve, BF, Bordelon, YM, Miller, B, Burn, DJ, Chan, D, Corvol, JC, Couratier, P, Dayalu, P, Doody, R, Driver-Dunkley, E, Ferrara, J, Golbe, LI, Graff-Radford, NR, Grimes, D, Grossman, M, Gunzler, S, Hillis, AE, Höglinger, G, Honig, L, Lang, A, Lees, A, Litvan, I, Isaacson, SH, Jankovic, J, Jog, MS, Kaufer, DI, Kumar, R, Lafontaine, AL, Leegwater-Kim, J, Lessig, S, Lew, MF, Lipp, A, Lobach, I, Lorenzl, SP, Ludolph, A, Marras, C, McGinnis, S, Mollenhauer, B, Pahwa, R, Panisset, M, Reichmann, H, Roberson, E, Santiago, A, Schneider, L, Tuite, P, Williams, D, Woitalla, D, Womack, KB, Xie, T, Zamrini, E, Zermansky, A, Zesiewicz, TA
Publikováno v: Hewer, S; Varley, S; Boxer, AL; Paul, E; Williams, DR; Azulay, JP; et al.(2016). Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale. Movement Disorders, 31(10), 1574-1577. doi: 10.1002/mds.26694. UCSF: Retrieved from: http://www.escholarship.org/uc/item/45r9f3g0
© 2016 2016 International Parkinson and Movement Disorder Society Background: Despite the widespread use of the Progressive Supranuclear Palsy Rating Scale (PSPRS), it is not known what change in this scale is meaningful for patients. Methods: We an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::bebc33020c2bdb3c846c2f0e83639c40
http://www.escholarship.org/uc/item/45r9f3g0
Zobrazit plný text záznamu
4
Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy
Autor: Tsai, RM, Lobach, I, Bang, J, Whitwell, JL, Senjem, ML, Jack, CR, Rosen, H, Miller, B, Boxer, AL, Williams, D, Lafontaine, AL, Marras, C, Jog, M, Panisset, M, Lang, A, Parker, L, Stewart, AJ, Corvol, JC, Azulay, JP, Couratier, P, Mollenhauer, B, Lorenzl, S, Ludolph, A, Benecke, R, Hoglinger, G, Lipp, A, Reichmann, H, Woitalla, D, Chan, D, Zermansky, A, Burn, D, Lees, A, Gozes, I, Boxer, A, Miller, BL, Lobach, IV, Roberson, ED, Honig, L, Zamrini, E, Pahwa, R, Bordelon, Y, Driver-Dunkley, E, Lessig, S, Lew, M, Womack, K, Boeve, B, Ferrara, J, Hillis, A, Kaufer, D, Kumar, R, Xie, T, Gunzler, S, Zesiewicz, T, Dayalu, P, Golbe, L, Jankovic, J, McGinnis, S, Santiago, A, Tuite, P, Isaacson, S, Leegwater-Kim, J, Litvan, I, Grossman, M, Knopman, DS, Schneider, LS, Doody, RS, Golbe, LI, Koestler, M, Deerlin, VV, Randolph, C, Whitaker, S, Hirman, J, Gold, M, Morimoto, BH
Publikováno v: Tsai, RM; Lobach, I; Bang, J; Whitwell, JL; Senjem, ML; Jack, CR; et al.(2016). Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy. Parkinsonism and Related Disorders, 28, 29-35. doi: 10.1016/j.parkreldis.2016.04.006. UCSF: Retrieved from: http://www.escholarship.org/uc/item/1v89z6zw
© 2016 . Introduction: There are no effective treatments for progressive supranuclear palsy (PSP). Volumetric MRI (vMRI) may be a useful surrogate outcome measure in PSP clinical trials. The goal of the study was to evaluate the potential of vMRI to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::ab93d3e7bbf27b70372bf0fd182b8ff6
http://www.escholarship.org/uc/item/1v89z6zw
Zobrazit plný text záznamu
6
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
Autor: Höglinger, GU, Melhem, NM, Dickson, DW, Sleiman, PMA, Wang, LS, Klei, L, Rademakers, R, De Silva, R, Litvan, I, Riley, DE, Van Swieten, JC, Heutink, P, Wszolek, ZK, Uitti, RJ, Vandrovcova, J, Hurtig, HI, Gross, RG, Maetzler, W, Goldwurm, S, Tolosa, E, Borroni, B, Pastor, P, Cantwell, LB, Han, MR, Dillman, A, Van Der Brug, MP, Gibbs, JR, Cookson, MR, Hernandez, DG, Singleton, AB, Farrer, MJ, Yu, CE, Golbe, LI, Revesz, T, Hardy, J, Lees, AJ, Devlin, B, Hakonarson, H, Müller, U, Schellenberg, GD, Albin, RL, Alonso, E, Antonini, A, Apfelbacher, M, Arnold, SE, Avila, J, Beach, TG, Beecher, S, Berg, D, Bird, TD, Bogdanovic, N, Boon, AJW, Bordelon, Y, Brice, A, Budka, H, Canesi, M, Chiu, WZ, Cilia, R, Colosimo, C, De Deyn, PP, De Yebenes, JG, Kaat, LD, Duara, R, Durr, A, Engelborghs, S, Fabbrini, G, Finch, NA, Flook, R, Frosch, MP, Gaig, C, Galasko, DR, Gasser, T, Gearing, M, Geller, ET, Ghetti, B, Graff-Radford, NR, Grossman, M, Hall, DA, Hazrati, LN, Höllerhage, M, Jankovic, J, Juncos, JL, Karydas, A, Kretzschmar, HA, Leber, I
Publikováno v: Höglinger, GU; Melhem, NM; Dickson, DW; Sleiman, PMA; Wang, LS; Klei, L; et al.(2011). Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nature Genetics, 43(7), 699-705. doi: 10.1038/ng.859. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/3z78h0m8
Progressive supranuclear palsy (PSP) is a movement disorder with prominent tau neuropathology. Brain diseases with abnormal tau deposits are called tauopathies, the most common of which is Alzheimer's disease. Environmental causes of tauopathies incl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::cc034780128dd53bae83a2a33500310a
http://www.escholarship.org/uc/item/3z78h0m8
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje